Advertisement

Systemic Lupus Erythematosus and Pregnancy

  • Hiralal Konar
  • Picklu Chaudhuri
Chapter

Abstract

Systemic lupus erythematosus (SLE) is a multisystem connective tissue disease characterized by multi-organ involvement; characteristic inflammatory lesions of the skin, joints, serous membranes, kidneys and CNS; and its association with high titres of autoantibodies to an array of autoantigens. Its clinical course is often one of the disease flares followed by variable periods of remission. Approximately 90 % of the affected population are young women in their second or third decades of life. Therefore, SLE is the commonest connective tissue disorder encountered during pregnancy, and it has been widely studied by researchers across the globe. Evidence shows the foetal and maternal outcomes are adversely affected by the disease.

Keywords

Systemic Lupus Erythematosus Preterm Birth Foetal Growth Restriction Anticardiolipin Antibody Gestational Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Mintz G, Niz J, Gutierrez G, et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986;13:732.PubMedGoogle Scholar
  2. 2.
    Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus. 1993;2:115–8.CrossRefPubMedGoogle Scholar
  3. 2a.
    Hochberg MC. Prevalence of systemic lupus erythematosus in England and Wales (1981–82). Ann Rheum Dis. 1987;46:664–6.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 2b.
    Jonsson H, Nived O, Surfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore). 1989;68:141–50.CrossRefGoogle Scholar
  5. 2c.
    Uramoto KM, Michet Jr CJ, Thumboo J, et al. Trends in the incidence and mortality 1950–1992. Arthritis Rheum. 1992;42:46–50.CrossRefGoogle Scholar
  6. 3.
    Fraga A, Mintz G, Orozco J, Orozco JH. Sterility and fertility rates, foetal wastage and maternal morbidity in Systemic lupus erythematosus. J Rheumatol. 1974;1:1293–8.Google Scholar
  7. 4.
    Garsenstein M, Pollak VE, Karik RM. Systemic lupus erythematosus and pregnancy. N Engl J Med. 1962;267:165–9.CrossRefPubMedGoogle Scholar
  8. 5.
    Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum. 1989;32:665.CrossRefPubMedGoogle Scholar
  9. 6.
    Urowitz MB, Gladman DD, Farewell VT, et al. Lupus and pregnancy studies. Arthritis Rheum. 1993;36:1392.CrossRefPubMedGoogle Scholar
  10. 7.
    Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center Experience. Arthritis Rheum. 1991;34:1538.CrossRefPubMedGoogle Scholar
  11. 8.
    Lockshin MD, Reinitz E, Druzin ML, et al. Lupus pregnancy. Case–control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med. 1984;77:893.CrossRefPubMedGoogle Scholar
  12. 9.
    Denney JM, Porter TF, Branch DW. Autoimmune disease, Chapter 43, High risk pregnancy, management options, 4th ed. Elsevier Saunders. Egerman RS, Ramsey RD.Google Scholar
  13. 10.
    Kao LW, et al. Hypertensive disease in pregnancies complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;193:1676.CrossRefPubMedGoogle Scholar
  14. 11.
    Johnson MJ, Petri M, Witter FR, Repke JT. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol. 1995;86:396.CrossRefPubMedGoogle Scholar
  15. 12.
    Hochberg MC. Updating The American College of Rheumatology revised criteria for the classification of Systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.CrossRefPubMedGoogle Scholar
  16. 13.
    Repke JT. Hypertensive disorders of pregnancy. Differentiating preeclampsia from active systemic lupus erythematosus. J Reprod Med. 1998;43:350.PubMedGoogle Scholar
  17. 14.
    Buyon JP, Cronstein BN, Morris M, et al. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Am J Med. 1986;81:194.CrossRefPubMedGoogle Scholar
  18. 15.
    Al-Herz A, Schulzer M, Esdaile JM. Survey of antimalarial use in lupus pregnancy and lactation. J Rheumatol. 2002;29:700.PubMedGoogle Scholar
  19. 16.
    Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003;48:3207.CrossRefPubMedGoogle Scholar
  20. 17.
    Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54:3640.CrossRefPubMedGoogle Scholar
  21. 18.
    Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus. 2005;14:593.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of Obstetrics & GynaecologyCalcutta National Medical College & HospitalSalt Lake City, KolkataIndia
  2. 2.Department of Obstetrics & GynaecologyN.R.S. Medical CollegeKolkataIndia

Personalised recommendations